NASDAQ NMS - GLOBAL MARKET · BJDX
+2.99% · +$0.0400 · Vol 12.9M
After hours · updated 19:27:07 ET
Bluejay Diagnostics Inc

Bluejay Diagnostics Inc

Health Care
$1.38

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BJDX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bluejay Diagnostics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
6
Country
US

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.50
Day high
$1.61
Day low
$1.37
Previous close
$1.34
52W high
$4.79
-71.19% from high
52W low
$1.12
7% of range
Market cap
$1.4M
EPS
$-7.7400
Shares out
1M
Volume
12.9M
VWAP
$1.59
Price history computed in-house
1W
+23.21%
1M
-69.27%
SMA 50 $2.97 · below
SMA 200 $2.97 · below
52W position 7%
Veridion warehouse edge

Warehouse intelligence for BJDX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BJDX insider activity

Bluejay Diagnostics Inc

Score
Coverage building
Pressure
Net buying
Filings
5
Buys / sells
5 / 0
Net value
$125K
Insiders
5
Named filers
WC
Wurth Douglas Clark
Insider
Leadership
DI
Dey Indranil
Insider
Leadership
ZS
ZEIDMAN FRED S
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $125K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-182026-03-14Wurth Douglas ClarkInsiderbuy$2.0012,50012,608$25KSEC Form 4
2026-05-182026-03-14Dey IndranilInsiderbuy$2.0012,50012,522$25KSEC Form 4
2026-05-182026-03-14ZEIDMAN FRED SInsiderbuy$2.0012,50012,500$25KSEC Form 4
2026-05-182026-03-14Dey SvetlanaInsiderbuy$2.0012,50012,501$25KSEC Form 4
2026-05-182026-03-14CHASE DONALD RInsiderbuy$2.0012,50012,525$25KSEC Form 4
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BJDX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BJDX in this window.
Lobbying spend

BJDX lobbying filings, year to date.

Registered lobbying filings matched to Bluejay Diagnostics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BJDX in this window.
Latest news · BJDX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BJDX.
Options
Sovereign unlock shows live options positioning for BJDX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.